Skip to content

DIPB vs. SIFIB for Postoperative Analgesia After Hip Surgery

Comparison of the Effects of Deep Iliacus Plane Block (DIPB) and Suprainguinal Fascia Iliaca Block (SIFIB) on Postoperative Analgesia in Patients Undergoing Hip Surgery: A Randomized Controlled Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07452120
Enrollment
70
Registered
2026-03-05
Start date
2026-03-27
Completion date
2026-11-01
Last updated
2026-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip Arthroplasty, Postoperative Pain, Regional Anesthesia, Acute Postoperative Pain

Keywords

Deep Iliacus Plane Block, Suprainguinal Fascia Iliaca Block, Hip Arthroplasty, Postoperative Pain, Regional Anesthesia

Brief summary

This randomized, double-blind clinical trial aims to compare the effectiveness of the Deep Iliacus Plane Block (DIPB) and the Suprainguinal Fascia Iliaca Block (SIFIB) for postoperative pain control in patients undergoing primary total hip arthroplasty. Effective analgesia after hip surgery is essential for early mobilization, reduction of complications, and improved recovery outcomes. Seventy patients scheduled for elective hip arthroplasty under spinal anesthesia will be randomly assigned to receive either DIPB or SIFIB at the end of surgery. Postoperative pain scores, opioid consumption, motor block, and block-related complications will be evaluated over a 48-hour period. The study aims to determine whether DIPB provides superior or comparable analgesia with reduced motor blockade compared to SIFIB, thereby contributing to safer and more comprehensive postoperative pain management in hip surgery patients.

Detailed description

Hip arthroplasty is frequently associated with moderate to severe postoperative pain, which may negatively affect early mobilization, rehabilitation, and overall recovery. Adequate postoperative analgesia is therefore essential to reduce complications such as pulmonary morbidity, thromboembolism, delirium, and prolonged hospital stay. The hip joint is innervated by both deep articular branches (femoral, obturator, and accessory obturator nerves) and superficial cutaneous branches (femoral nerve and lateral femoral cutaneous nerve). An optimal regional analgesic technique should provide effective blockade of both components. However, currently used techniques often fail to adequately block deep capsular innervation while preserving motor function. The suprainguinal fascia iliaca block (SIFIB) is widely used in hip surgery and effectively blocks the femoral nerve and lateral femoral cutaneous nerve, providing reliable cutaneous analgesia. Nevertheless, insufficient spread to obturator and accessory obturator nerves may result in inadequate deep joint analgesia. Attempts to overcome this limitation using high-volume injections may increase the risk of quadriceps weakness and motor blockade. The Deep Iliacus Plane Block (DIPB) is a recently described fascial plane block targeting the deep surface of the iliacus muscle at the level of the anterior inferior iliac spine. Anatomical and preliminary clinical findings suggest that DIPB allows spread of local anesthetic to femoral, lateral femoral cutaneous, and pericapsular articular branches of the hip joint, potentially providing both capsular and cutaneous analgesia with reduced motor impairment. DIPB has therefore been proposed as a hybrid technique combining advantages of existing regional blocks. This prospective, randomized, controlled, double-blind clinical trial will be conducted at Sivas Numune Hospital. Seventy patients (ASA I-III) scheduled for elective primary total hip arthroplasty under spinal anesthesia will be enrolled and randomly assigned into two groups: the SIFIB group (n=35) and the DIPB group (n=35). Randomization will be performed using a computer-generated sequence. All patients will receive standardized spinal anesthesia and multimodal systemic analgesia. At the end of surgery, ultrasound-guided SIFIB or DIPB will be performed by an experienced anesthesiologist using 0.25% bupivacaine (30-40 mL, weight-adjusted). Postoperative pain will be assessed using the Numeric Rating Scale (NRS) at rest and during movement at predetermined intervals up to 48 hours. Rescue analgesia with intravenous tramadol will be administered when NRS ≥4, and total opioid consumption will be recorded. Motor blockade will be evaluated using the modified Bromage scale. Block-related complications and adverse events will also be documented. The primary aim of the study is to compare postoperative pain scores and opioid consumption between DIPB and SIFIB. Secondary outcomes include motor blockade, block-related complications, and overall analgesic effectiveness. The findings of this study are expected to clarify whether DIPB provides superior or comparable analgesia with less motor impairment, thereby contributing to safer and more comprehensive postoperative pain management in hip arthroplasty patients.

Interventions

Ultrasound-guided suprainguinal fascia iliaca compartment block performed at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

PROCEDUREDeep Iliacus Plane Block

Ultrasound-guided deep iliacus plane block performed at the end of surgery using 0.25% bupivacaine (30-40 mL, weight-adjusted) for postoperative analgesia following primary total hip arthroplasty.

Sponsors

Sivas Numune Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Participants will be randomly assigned to one of two parallel groups to receive either Deep Iliacus Plane Block (DIPB) or Suprainguinal Fascia Iliaca Block (SIFIB). Both interventions will be performed at the end of surgery, and outcomes will be assessed concurrently over a 48-hour postoperative period to compare analgesic efficacy, opioid consumption, motor blockade, and safety profiles between groups.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged ≥18 years * ASA physical status I-III * Scheduled for elective primary total hip arthroplasty under spinal anesthesia * Ability to understand the study procedures and provide informed consent

Exclusion criteria

* Coagulation disorders or anticoagulant therapy contraindicating regional anesthesia * Infection at the block application site * Hemodynamic instability * Known allergy to local anesthetics * Pre-existing significant neurological or motor deficits in the lower extremities * Cognitive impairment preventing pain assessment * Refusal to participate or inability to provide informed consent

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain intensity2, 4, 8, 16, 24, and 48 hours postoperativelyPostoperative pain assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst pain imaginable) at rest and during movement following total hip arthroplasty.

Secondary

MeasureTime frameDescription
Opioid consumptionFrom the end of surgery to 48 hours postoperativelyTotal rescue opioid consumption (intravenous tramadol) administered for postoperative pain management.
Motor block4, 8, 16, 24, and 48 hours postoperativelyMotor blockade assessed using the Modified Bromage Scale (0-3), where higher scores indicate greater motor impairment of the lower extremity following regional anesthesia.
Pain during movement2, 4, 8, 16, 24, and 48 hours postoperativelyPain during movement assessed using the Numeric Rating Scale (NRS; 0 = no pain, 10 = worst imaginable pain), where higher scores indicate greater pain intensity.

Countries

Turkey (Türkiye)

Contacts

CONTACTFatih Balcı, MD
fatihbalci05@gmail.com+90 545 864 76 57
PRINCIPAL_INVESTIGATORFatih BALCI

Sivas Numune Hospital, Department of Anesthesiology and Reanimation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 3, 2026